Quest Diagnostics Incorporated (DGX) earnings: date, estimates, results and stock reactions
Next earnings: Q4 FY2026 on 2027-02-09 (expected, before the open). EPS estimate 2.68, revenue estimate 3.04B.
Over the last 12 reports the stock moved 5.0% on average (either way), rising 9 times and falling 3. EPS beat estimates 12 of 12 times; revenue 12 of 12. Close before the report date to the first close after it (two trading sessions, covering before-the-open and after-the-close reports).
| Quarter | Reported | EPS | EPS estimate | EPS surprise | Revenue | Revenue estimate | Stock move |
|---|---|---|---|---|---|---|---|
| Q3 FY2026 | 2026-10-22 | 3.00 | 2.87 | +4.5% | 3.10B | 3.05B | +1.2% |
| Q2 FY2026 | 2026-07-23 | 3.12 | 2.82 | +10.6% | 3.04B | 2.97B | +8.6% |
| Q1 FY2026 | 2026-04-21 | 2.50 | 2.37 | +5.5% | 2.90B | 2.83B | +3.9% |
| Q4 FY2025 | 2026-02-10 | 2.42 | 2.36 | +2.5% | 2.81B | 2.75B | +9.4% |
| Q3 FY2025 | 2025-10-21 | 2.60 | 2.50 | +4.0% | 2.82B | 2.74B | -4.9% |
| Q2 FY2025 | 2025-07-22 | 2.62 | 2.57 | +1.9% | 2.76B | 2.73B | +2.4% |
| Q1 FY2025 | 2025-04-22 | 2.21 | 2.15 | +2.8% | 2.65B | 2.63B | +7.2% |
| Q4 FY2024 | 2025-01-30 | 2.23 | 2.19 | +1.8% | 2.62B | 2.58B | +4.9% |